Piramal Pharma shines on reporting 2- fold jump in Q4 consolidated net profit

13 May 2024 Evaluate

Piramal Pharma is currently trading at Rs. 160.50, up by 10.20 points or 6.79% from its previous closing of Rs. 150.30 on the BSE.

The scrip opened at Rs. 157.25 and has touched a high and low of Rs. 166.60 and Rs. 155.30 respectively. So far 1224481 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 166.60 on 13-May-2024 and a 52 week low of Rs. 69.91 on 19-May-2023.

Last one week high and low of the scrip stood at Rs. 166.60 and Rs. 144.00 respectively. The current market cap of the company is Rs. 21233.32 crore.

The promoters holding in the company stood at 35.02%, while Institutions and Non-Institutions held 42.71% and 22.26% respectively.

Piramal Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported over 6-fold jump in its net profit at Rs 273.08 crore for the quarter under review as compared to Rs 41.70 crore for the same quarter in the previous year. Total income of the company increased by 41.26% at Rs 1,578.49 crore for Q4FY24 as compared Rs 1,117.46 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 2-fold jump in its net profit at Rs 101.27 crore for fourth quarter ended March 31, 2024 as compared to Rs 50.11 crore for the same quarter in the previous year. Total income of the company increased by 17.85% at Rs 2,578.74 crore for Q4FY24 as compared Rs 2,188.08 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported over 5-fold jump in net profit at Rs 391.22 crore as compared to Rs 69.50 crore for the previous year. Total income of the company increased by 21.35% at Rs 4,592.17 crore for year under review as compared to Rs 3,784.29 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported net profit at Rs 17.82 crore as compared to net loss of Rs 186.46 crore for the previous year. Total income of the company increased by 14.23% at Rs 8,346.55 crore for year under review as compared to Rs 7,306.66 crore for year ended March 31, 2023.

Piramal Pharma Share Price

252.60 -9.00 (-3.44%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.